0001144204-15-061931.txt : 20151030 0001144204-15-061931.hdr.sgml : 20151030 20151030163031 ACCESSION NUMBER: 0001144204-15-061931 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151028 FILED AS OF DATE: 20151030 DATE AS OF CHANGE: 20151030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: China Biologic Products, Inc. CENTRAL INDEX KEY: 0001369868 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 752308816 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100125 BUSINESS PHONE: 86-10-6598-3111 MAIL ADDRESS: STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100125 FORMER COMPANY: FORMER CONFORMED NAME: GRC Holdings, Inc. DATE OF NAME CHANGE: 20060721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gao David CENTRAL INDEX KEY: 0001331795 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34566 FILM NUMBER: 151187873 MAIL ADDRESS: STREET 1: C/ BEIJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 v423308_4.xml OWNERSHIP DOCUMENT X0306 4 2015-10-28 0 0001369868 China Biologic Products, Inc. CBPO 0001331795 Gao David 18TH FLOOR, JIALONG INTERNATIONAL BUILDING, 19 CHAOYANG PARK ROAD BEIJING F4 100125 CHINA 1 1 0 0 Chief Executive Officer Common Stock 2015-10-28 4 S 0 61660 110.23 D 495340 D Common Stock 2015-10-29 4 S 0 9458 110.08 D 485882 D Represents 71,118 shares of common stock sold through a 10b5-1 trading plan previously disclosed on the Reporting Person's Form 4 filed with the Securities and Exchange Commission (the "Commission") on October 21, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $110.00 to $110.78, inclusive.* The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $110.00 to $110.96, inclusive.* * The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3. /s/ David (Xiaoying) Gao 2015-10-30